Dissolved and financials
CVR: 39904276
DKK -382,113
Gross profit
Net result: DKK -2,671,977
No owners listed
CVR · view owners
No current management
CVR · view management
Dissolved
Ceased 20 July 2026
CVR · view overview
2 employees
CVR · 2024
Director role ended: Mette Marie Rosenkilde
CVR · 24/02/2025
View the full event history
Bainan Biotech ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company has been dissolved on 20 July 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a gross profit of DKK -382,113 and a net result of DKK -2,671,977 compared with DKK -3,128,882 the year before. Equity in the 2023 report amounted to DKK -15,215,743.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202301/01/2023 – 31/12/2023 | -382K | -2.7M | 2.9M | -15.2M | 1 | |
| 202201/01/2022 – 31/12/2022 | -1.2M | -3.1M | 3.7M | -12.5M | 4 | |
| 202101/01/2021 – 31/12/2021 | -3.7M | -9.1M | 5.6M | -9.4M | 9 | |
| 202001/01/2020 – 31/12/2020 | 2M | -510K | 13.6M | -351K | 1 |
Compared to 1.037 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Indkaldelse til fordringsprøvelse i konkursboet Bainan Biotech ApS, Sø- og Handelsretten, sagsnr. K 345/25-K.
Source: Statstidende, updated daily
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringNo. Bainan Biotech ApS is registered in the Danish CVR register with the status Dissolved and ceased on 20 July 2026.
The CVR number of Bainan Biotech ApS is 39904276.
In 2023, Bainan Biotech ApS reported a gross profit of DKK -382,113.
Bainan Biotech ApS had 2 employees in 2024 according to the Danish CVR register.
Bainan Biotech ApS was founded on 27 September 2018.
Bainan Biotech ApS was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
Bainan Biotech ApS was dissolved on July 20, 2026.
On June 4, 2026, a notice regarding Bainan Biotech ApS was published in Statstidende: Indkaldelse til fordringsprøvelse (S02062026-341).
As of February 24, 2025, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Bainan Biotech ApS.
As of February 24, 2025, Jens Juul Holst has left the board of directors of Bainan Biotech ApS.
As of February 24, 2025, Bolette Hartmann has left the board of directors of Bainan Biotech ApS.
As of February 24, 2025, Mette Marie Rosenkilde has stepped down as chairman of Bainan Biotech ApS.
As of February 24, 2025, Bolette Hartmann has stepped down as adm. dir. of Bainan Biotech ApS.
Bainan Biotech ApS has published its annual report for 2023. Gross profit came to DKK -382,113, and the net result was DKK -2,671,977.
Bainan Biotech ApS has published its annual report for 2022. Gross profit came to DKK -1,230,180, and the net result was DKK -3,128,882.
As of June 29, 2023, Bolette Hartmann is registered as adm. dir. of Bainan Biotech ApS.
As of June 29, 2023, Tue Alexander Emborg has stepped down as adm. dir. of Bainan Biotech ApS.
As of June 1, 2023, Tue Alexander Emborg is registered as adm. dir. of Bainan Biotech ApS.
As of June 1, 2023, Bolette Hartmann has stepped down as adm. dir. of Bainan Biotech ApS.
As of May 15, 2023, Arvind Mansha Hundal has left the board of directors of Bainan Biotech ApS.
Bainan Biotech ApS has published its annual report for 2021. Gross profit came to DKK -3,709,804, and the net result was DKK -9,063,823.
As of November 10, 2021, Bolette Hartmann is registered as adm. dir. of Bainan Biotech ApS.
As of November 10, 2021, Ditte Riber has stepped down as adm. dir. of Bainan Biotech ApS.
Bainan Biotech ApS has published its annual report for 2020. Gross profit came to DKK 1,952,827, and the net result was DKK -509,902.
As of May 7, 2021, Ditte Riber is registered as adm. dir. of Bainan Biotech ApS.
As of May 7, 2021, Tue Alexander Emborg has stepped down as director of Bainan Biotech ApS.
As of December 1, 2020, Arvind Mansha Hundal has joined the board of directors of Bainan Biotech ApS.
As of November 15, 2020, EY Godkendt Revisionspartnerselskab has been appointed auditor of Bainan Biotech ApS.
As of November 15, 2020, Mette Marie Rosenkilde is registered as chairman of Bainan Biotech ApS.
As of November 14, 2020, Mette Marie Rosenkilde has left the board of directors of Bainan Biotech ApS.
Bainan Biotech ApS has published its interim report for the period September 27, 2018 to December 31, 2019.
As of September 27, 2018, Mette Marie Rosenkilde has joined the board of directors of Bainan Biotech ApS.
As of September 27, 2018, Jens Juul Holst has joined the board of directors of Bainan Biotech ApS.
As of September 27, 2018, Bolette Hartmann has joined the board of directors of Bainan Biotech ApS.
As of September 27, 2018, Tue Alexander Emborg is registered as director of Bainan Biotech ApS.
Bainan Biotech ApS was founded on September 27, 2018.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Companies in the same industry and area
CVR 36465972
CVR 45436497
CVR 46059220
CVR 41978074
CVR 46543912
